Invention Grant
US09540324B2 Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
有权
NR2B选择性八氢环戊二烯[C]吡咯负调节剂
![Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B](/docs/US/2017-01-10/US09540324B2/abs.jpg.600x600.jpg)
- Patent Title: Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent Title (中): NR2B选择性八氢环戊二烯[C]吡咯负调节剂
-
Application No.: US14498462Application Date: 2014-09-26
-
Publication No.: US09540324B2Publication Date: 2017-01-10
- Inventor: David R. Anderson , Robert A. Volkmann , Frank S. Menniti
- Applicant: Mnemosyne Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: LUC THERAPEUTICS, INC.
- Current Assignee: LUC THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Brinks Gilson & Lione
- Main IPC: C07D209/52
- IPC: C07D209/52 ; C07D403/12 ; C07D401/04 ; C07D401/06 ; C07D401/10 ; C07D401/12 ; C07D403/04 ; C07D403/06 ; C07D403/10 ; C07D403/14 ; C07D413/06 ; C07D205/04 ; C07D401/14 ; C07D487/04
![Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B](/abs-image/US/2017/01/10/US09540324B2/abs.jpg.150x150.jpg)
Abstract:
Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
Public/Granted literature
- US20150225342A1 SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B Public/Granted day:2015-08-13
Information query
